Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Alkermes Inc. plc

ALKS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

$ALKS is featured in our U.S. House Long-Short and Congress Long-Short strategies.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of ALKS by members of U.S. Congress

ALKS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
ALKS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
ALKS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in ALKS holdings by institutional investors

Quarterly net insider trading by ALKS's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for ALKS

73 former government officials from 40 congressional offices at 19 lobbying firms have lobbied for ALKS, most recently Aug 13, 2026.

  • James C. Greenwood
    Joel White House New Staff Director, Ways & Means Health Subcommittee; L.A. for Rep. Jim Greenwood; L.A. for Rep. Chris Shays Formerly with James C. Greenwood · MONUMENT ADVOCACY · Aug 13, 2026
  • J. Robert Kerrey
    Sarah Egge Senate Sarah: 1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee for Deficit Reduction Formerly with J. Robert Kerrey · SPLITOAK STRATEGIES LLC · Aug 03, 2026
  • Daniel Todd Senate Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid Formerly Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Ad · TODD STRATEGY GROUP · Jul 20, 2026
  • Nicholas Uehlecke House Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee Formerly Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legis · TODD STRATEGY GROUP · Jul 20, 2026
  • Brett Guthrie
    Eric Bergren House Chief of Staff, Rep. Brett Guthrie; Staff Assistant, Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Chief of Staff - Rep. Ron Lewis; Intern, Rep. Bill Baker Formerly with Brett Guthrie · TODD STRATEGY GROUP · Jul 20, 2026
  • Brett Guthrie
    Katherine Cotton House Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie Formerly with Brett Guthrie · TODD STRATEGY GROUP · Jul 20, 2026
  • John B. Shadegg
    Paul Edattel House Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg Formerly with John B. Shadegg · TODD STRATEGY GROUP · Jul 20, 2026
  • Elizabeth Warren
    Remy Mason Senate Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz Formerly with Elizabeth Warren · BGR GOVERNMENT AFFAIRS · Jul 20, 2026
See all 73 on the Revolving Door dashboard

ALKS Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

ALKS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
ALKS Income Statement
ALKS Balance Sheet
ALKS Cash Flow
U.S. Patents

New ALKS patent grants

  • Patent Title: Substituted carbamate macrocyclic compounds and related methods of treatment May. 26, 2026
  • Patent Title: Substituted piperidino compounds and related methods of treatment Oct. 14, 2025
  • Patent Title: Substituted macrocyclic compounds and related methods of treatment Aug. 06, 2024
  • Patent Title: Substituted macrocyclic compounds and related methods of treatment Jun. 11, 2024
  • Patent Title: Bicyclic inhibitors of histone deacetylase May. 21, 2024
  • Patent Title: Substituted pyridines as inhibitors of histone deacetylase Feb. 27, 2024
  • Patent Title: Hetero-halo inhibitors of histone deacetylase Jan. 02, 2024
  • Patent Title: Substituted piperidino compounds and related methods of treatment Sep. 19, 2023
  • Patent Title: Substituted macrocyclic compounds and related methods of treatment Jan. 03, 2023
  • Patent Title: Compositions and methods for modulating il-10 immunostimulatory and anti-inflammatory properties Dec. 27, 2022
  • Patent Title: Bicyclic inhibitors of histone deacetylase Mar. 29, 2022
  • Patent Title: Bicyclic inhibitors of histone deacetylase Jan. 18, 2022
  • Patent Title: Substituted pyridines as inhibitors of histone deacetylase Jan. 18, 2022
  • Patent Title: Hetero-halo inhibitors of histone deacetylase Feb. 16, 2021
  • Patent Title: Single chain fc fusion proteins Jan. 05, 2021
  • Patent Title: Compositions for modulating il-10 immunostimulatory and anti-inflammatory properties Jul. 02, 2019
  • Patent Title: Fusion polypeptides comprising mucin-domain polypeptide linkers Jan. 22, 2019
  • Patent Title: Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide Jul. 17, 2018
  • Patent Title: Peripherally acting opioid compounds Oct. 03, 2017
  • Patent Title: Ligands modified by circular permutation as agonists and antagonists Aug. 30, 2016
  • Patent Title: Peripherally acting opioid compounds Aug. 16, 2016
  • Patent Title: Ligands modified by circular permutation as agonists and antagonists Jun. 07, 2016
  • Patent Title: Fusion polypeptides comprising mucin-domain polypeptide linkers Mar. 29, 2016
  • Patent Title: Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide Oct. 13, 2015
  • Patent Title: Selective opioid compounds May. 26, 2015
  • Patent Title: Process for the synthesis of quaternary amine compounds May. 12, 2015
  • Patent Title: Polymorphic forms of naltrexone Mar. 10, 2015
  • Patent Title: Peripherally acting opioid compounds Feb. 24, 2015
  • Patent Title: Polymorphic forms of naltrexone May. 27, 2014
  • Patent Title: Polymorphic forms of naltrexone Mar. 05, 2013
  • Patent Title: Selective opioid compounds Jan. 15, 2013
  • Patent Title: Methods for administering aripiprazole Dec. 25, 2012
  • Patent Title: Methods for administering aripiprazole Dec. 25, 2012
  • Patent Title: Naltrexone long acting formulations and methods of use Apr. 05, 2011
  • Patent Title: Pulmonary delivery for levodopa Feb. 01, 2011
  • Patent Title: Residual solvent extraction method and microparticles produced thereby Jan. 25, 2011
  • Patent Title: Formulations for spray-drying large porous particles Oct. 05, 2010
  • Patent Title: Inhalable sustained therapeutic formulations Jul. 13, 2010
  • Patent Title: Particles for inhalation having sustained release properties Mar. 16, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to ALKS from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
ALKS News

Recent insights relating to ALKS

CNBC Recommendations

Recent picks made for ALKS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ALKS

ALKS Analyst Ratings

ALKS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
ALKS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $ALKS stock a Buy, Sell, or Hold?

  • What is the price target for $ALKS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

ALKS Top Shareholders
Shareholder
Shares Held
ALKS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $ALKS stock?

  • Who owns the most shares of $ALKS stock?

  • What funds own $ALKS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

ALKS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view ALKS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About ALKS

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

  • Address Dublin 4, L2
  • Market Cap 7.3 billion
  • Employees 2,050
  • Industrial Classification Pharmaceutical Preparations

Alkermes Inc. plc (ALKS) Historical Stock Prices

Alkermes Inc. plc (ALKS) closed at $43.29 on September 22, 2026. Over the past year its adjusted close ranged from $27.13 to $55.22. Daily prices go back to January 2, 2014, 3,197 trading days in all.

  • 1 month-10.43%
  • 3 months-9.94%
  • Year to date+54.72%
  • 1 year+56.68%
  • 3 years+56.01%
  • 5 years+41.87%
  • Max+12.51%
See every congressional and insider trade on the ALKS price chart

Quiver Premium charts ALKS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 44.39 44.53 43.08 43.29 43.29 2,310,733
Sep 21, 2026 44.27 44.79 43.11 44.18 44.18 3,732,232
Sep 18, 2026 46.51 46.53 43.27 43.39 43.39 6,935,802
Sep 17, 2026 47.10 47.40 46.41 46.71 46.71 1,423,622
Sep 16, 2026 46.64 47.26 45.78 46.07 46.07 1,854,651
Sep 15, 2026 45.73 46.14 44.63 46.03 46.03 2,151,164
Sep 14, 2026 46.60 46.60 45.66 45.83 45.83 2,029,453
Sep 11, 2026 46.75 46.75 45.73 45.97 45.97 1,283,128
Sep 10, 2026 44.98 46.11 44.75 46.11 46.11 1,193,903
Sep 9, 2026 45.24 45.60 44.72 45.40 45.40 1,442,769
Sep 8, 2026 45.20 46.53 44.63 45.49 45.49 1,355,832
Sep 4, 2026 46.14 46.93 45.80 46.10 46.10 1,064,034
Sep 3, 2026 48.01 48.29 46.71 46.88 46.88 974,512
Sep 2, 2026 47.70 48.73 46.68 47.72 47.72 1,566,413
Sep 1, 2026 47.00 47.34 46.65 47.20 47.20 1,351,261
Aug 31, 2026 47.25 47.56 46.46 46.99 46.99 1,440,889
Aug 28, 2026 48.82 48.82 47.25 47.41 47.41 1,429,292
Aug 27, 2026 48.72 49.33 48.10 48.90 48.90 2,119,395
Aug 26, 2026 49.23 49.35 48.46 49.16 49.16 660,876
Aug 25, 2026 48.94 49.58 48.87 49.21 49.21 1,127,442
Aug 24, 2026 48.05 49.03 47.64 48.87 48.87 1,296,669
Aug 21, 2026 48.05 48.67 47.33 48.33 48.33 939,640
Aug 20, 2026 49.37 49.86 47.93 48.02 48.02 1,635,207
Aug 19, 2026 51.26 51.29 50.08 50.18 50.18 1,544,219
Aug 18, 2026 50.10 50.42 49.46 49.48 49.48 970,918
Aug 17, 2026 48.90 50.08 48.62 49.85 49.85 764,040
Aug 14, 2026 49.37 50.02 48.65 49.06 49.06 1,267,828
Aug 13, 2026 51.66 51.66 49.21 49.45 49.45 1,546,632
Aug 12, 2026 49.22 50.53 48.50 50.28 50.28 1,315,646
Aug 11, 2026 49.92 50.13 48.97 49.21 49.21 1,373,601
Aug 10, 2026 48.39 49.81 48.39 49.40 49.40 1,511,275
Aug 7, 2026 49.05 49.90 48.67 49.17 49.17 1,110,968
Aug 6, 2026 49.61 50.40 48.21 48.37 48.37 1,569,088
Aug 5, 2026 50.20 50.85 49.23 49.61 49.61 1,706,769
Aug 4, 2026 49.73 50.35 49.00 49.67 49.67 1,430,842
Aug 3, 2026 48.58 50.70 48.19 49.53 49.53 1,835,762
Jul 31, 2026 49.63 49.83 48.52 48.99 48.99 1,624,487
Jul 30, 2026 47.85 50.34 47.71 50.03 50.03 2,303,338
Jul 29, 2026 50.50 50.72 47.66 48.34 48.34 4,149,635
Jul 28, 2026 50.42 52.51 49.33 50.50 50.50 2,875,996
Jul 27, 2026 52.87 53.84 52.48 52.73 52.73 1,402,922
Jul 24, 2026 53.38 53.88 52.48 52.89 52.89 1,288,506
Jul 23, 2026 52.13 53.54 51.69 52.97 52.97 1,488,265
Jul 22, 2026 52.55 53.27 52.35 52.58 52.58 1,837,063
Jul 21, 2026 51.58 53.04 51.25 52.85 52.85 1,179,221
Jul 20, 2026 52.96 53.24 51.70 51.72 51.72 941,838
Jul 17, 2026 51.06 52.78 50.94 52.72 52.72 1,713,653
Jul 16, 2026 51.77 53.52 51.55 51.94 51.94 1,843,684
Jul 15, 2026 51.64 52.20 50.49 51.98 51.98 1,556,270
Jul 14, 2026 51.98 52.16 50.66 51.60 51.60 1,776,619
Jul 13, 2026 51.07 52.00 50.54 51.87 51.87 1,583,838
Jul 10, 2026 53.36 53.38 51.86 51.94 51.94 1,691,454
Jul 9, 2026 54.46 54.90 53.36 53.78 53.78 1,630,543
Jul 8, 2026 54.37 54.69 53.68 54.29 54.29 1,706,011
Jul 7, 2026 55.37 55.67 53.63 55.22 55.22 1,719,310
Jul 6, 2026 54.03 55.37 53.41 55.14 55.14 1,747,218
Jul 2, 2026 52.50 54.69 51.72 54.58 54.58 1,653,919
Jul 1, 2026 52.33 52.70 50.96 51.72 51.72 1,638,365
Jun 30, 2026 52.78 53.35 51.84 52.40 52.40 2,958,468
Jun 29, 2026 53.94 54.45 52.23 52.53 52.53 2,940,864
Jun 26, 2026 52.87 55.27 52.38 55.08 55.08 7,563,601
Jun 25, 2026 50.70 53.69 50.01 52.83 52.83 3,249,672
Jun 24, 2026 48.94 51.73 48.88 50.45 50.45 3,726,629
Jun 23, 2026 46.00 48.31 45.47 48.07 48.07 2,451,924
Jun 22, 2026 45.40 46.63 45.01 46.02 46.02 3,227,467
Jun 18, 2026 45.25 45.76 43.98 44.99 44.99 7,751,437
Jun 17, 2026 44.19 45.41 44.03 44.51 44.51 1,417,828
Jun 16, 2026 44.58 44.76 43.43 44.09 44.09 1,421,075
Jun 15, 2026 43.87 44.41 43.34 44.36 44.36 1,822,144
Jun 12, 2026 45.10 45.71 44.22 44.28 44.28 1,523,226
Jun 11, 2026 44.09 45.76 44.02 44.92 44.92 2,261,189
Jun 10, 2026 44.37 45.38 43.79 43.84 43.84 1,659,661
Jun 9, 2026 43.35 44.93 43.03 44.29 44.29 2,533,281
Jun 8, 2026 42.77 43.78 42.19 42.45 42.45 1,292,151
Jun 5, 2026 43.38 43.69 42.55 42.80 42.80 1,312,010
Jun 4, 2026 43.05 44.57 43.05 43.38 43.38 2,307,259
Jun 3, 2026 41.32 42.87 40.62 42.76 42.76 2,000,477
Jun 2, 2026 41.61 41.94 40.83 41.32 41.32 2,146,106
Jun 1, 2026 42.19 42.80 41.37 42.27 42.27 2,406,093
May 29, 2026 40.00 42.83 39.64 42.19 42.19 4,269,428
May 28, 2026 38.00 40.79 37.80 39.94 39.94 2,913,410
May 27, 2026 37.26 38.12 37.26 38.09 38.09 2,246,971
May 26, 2026 36.80 37.50 36.49 37.35 37.35 1,122,894
May 22, 2026 36.91 37.26 36.58 36.80 36.80 907,752
May 21, 2026 36.64 37.50 36.25 36.95 36.95 1,692,645
May 20, 2026 37.21 37.94 36.88 36.98 36.98 1,817,876
May 19, 2026 37.06 37.35 36.31 37.00 37.00 2,154,195
May 18, 2026 38.02 38.02 36.98 37.19 37.19 1,571,921
May 15, 2026 38.25 38.58 37.36 37.48 37.48 1,315,692
May 14, 2026 38.85 39.12 38.20 38.36 38.36 1,740,042
May 13, 2026 38.50 39.56 38.01 38.91 38.91 3,250,711
May 12, 2026 36.00 38.46 35.51 38.29 38.29 4,026,681
May 11, 2026 35.22 35.90 35.20 35.47 35.47 2,323,469
May 8, 2026 35.77 35.93 34.87 34.99 34.99 2,616,429
May 7, 2026 35.32 36.32 35.25 35.40 35.40 2,094,196
May 6, 2026 36.31 36.60 34.93 35.32 35.32 2,960,738
May 5, 2026 35.25 36.55 34.07 36.25 36.25 2,614,334
May 4, 2026 33.20 34.49 33.20 34.17 34.17 2,860,365
May 1, 2026 33.42 33.90 33.12 33.38 33.38 1,193,224
Apr 30, 2026 33.89 34.40 33.58 33.71 33.71 1,652,338
Apr 29, 2026 33.76 34.30 33.50 33.71 33.71 2,732,097
Apr 28, 2026 33.98 34.45 33.72 34.14 34.14 1,734,764
Apr 27, 2026 33.31 34.29 32.84 33.73 33.73 1,746,027
Apr 24, 2026 34.03 34.33 33.30 33.31 33.31 912,635
Apr 23, 2026 33.74 34.16 33.65 33.91 33.91 1,109,410
Apr 22, 2026 33.52 33.80 33.22 33.74 33.74 1,350,035
Apr 21, 2026 34.43 34.43 33.46 33.52 33.52 1,259,448
Apr 20, 2026 34.49 34.87 34.12 34.23 34.23 1,124,378
Apr 17, 2026 34.52 34.72 34.11 34.53 34.53 2,228,857
Apr 16, 2026 33.06 34.00 33.06 33.77 33.77 1,602,011
Apr 15, 2026 33.92 34.26 32.96 33.22 33.22 1,640,389
Apr 14, 2026 33.73 34.23 33.63 33.87 33.87 1,837,491
Apr 13, 2026 32.78 33.80 32.76 33.75 33.75 2,182,812
Apr 10, 2026 35.19 35.52 33.34 33.36 33.36 2,036,588
Apr 9, 2026 35.00 35.45 34.44 34.92 34.92 2,049,862
Apr 8, 2026 33.73 34.79 33.68 34.77 34.77 3,228,915
Apr 7, 2026 33.86 33.96 32.47 33.02 33.02 2,140,415
Apr 6, 2026 34.57 34.99 33.93 34.08 34.08 2,022,177
Apr 2, 2026 34.58 35.32 34.31 34.84 34.84 2,485,560
Apr 1, 2026 35.81 36.48 34.21 35.05 35.05 4,768,386
Mar 31, 2026 32.96 36.22 32.54 35.36 35.36 12,031,520
Mar 30, 2026 29.39 30.39 29.14 30.15 30.15 2,518,903
Mar 27, 2026 29.90 30.05 29.20 29.39 29.39 2,073,119
Mar 26, 2026 29.16 30.17 29.07 29.92 29.92 3,419,133
Mar 25, 2026 28.70 29.68 28.66 29.37 29.37 1,383,090
Mar 24, 2026 27.39 28.52 27.31 28.40 28.40 2,999,233
Mar 23, 2026 28.48 28.74 27.66 27.71 27.71 2,320,759
Mar 20, 2026 28.42 28.89 27.93 28.15 28.15 4,918,306
Mar 19, 2026 27.00 28.49 27.00 28.40 28.40 2,977,705
Mar 18, 2026 27.41 27.52 27.00 27.20 27.20 1,632,247
Mar 17, 2026 28.20 28.51 27.65 27.65 27.65 1,314,909
Mar 16, 2026 27.96 28.13 27.54 28.00 28.00 1,640,597
Mar 13, 2026 27.88 28.34 27.41 27.76 27.76 2,896,735
Mar 12, 2026 27.43 28.02 27.03 27.64 27.64 2,597,551
Mar 11, 2026 27.58 27.79 27.20 27.77 27.77 1,638,310
Mar 10, 2026 28.46 28.56 27.66 27.74 27.74 2,471,531
Mar 9, 2026 28.51 28.89 27.96 28.45 28.45 2,027,184
Mar 6, 2026 27.91 28.75 27.42 28.63 28.63 1,924,526
Mar 5, 2026 29.00 29.18 28.17 28.35 28.35 2,233,645
Mar 4, 2026 29.28 29.52 28.86 29.28 29.28 1,807,824
Mar 3, 2026 29.76 30.34 28.91 29.20 29.20 2,708,587
Mar 2, 2026 29.29 30.35 29.11 30.25 30.25 2,047,310
Feb 27, 2026 30.35 30.49 29.91 30.10 30.10 2,489,761
Feb 26, 2026 31.06 31.44 29.81 30.73 30.73 2,871,804
Feb 25, 2026 32.50 32.78 30.54 31.04 31.04 3,899,367
Feb 24, 2026 32.91 33.88 32.55 33.39 33.39 2,161,414
Feb 23, 2026 31.64 32.35 31.48 32.19 32.19 1,943,717
Feb 20, 2026 31.80 31.99 31.40 31.91 31.91 1,823,701
Feb 19, 2026 31.84 32.33 31.77 32.00 32.00 1,650,208
Feb 18, 2026 32.87 33.03 31.86 32.02 32.02 1,568,594
Feb 17, 2026 32.81 33.74 32.60 32.90 32.90 1,581,953
Feb 13, 2026 33.52 34.27 33.09 33.16 33.16 989,059
Feb 12, 2026 33.33 34.22 33.04 33.29 33.29 1,838,461
Feb 11, 2026 34.89 35.15 33.91 34.91 34.91 1,352,682
Feb 10, 2026 34.93 35.34 34.66 34.72 34.72 1,520,346
Feb 9, 2026 34.62 34.89 34.36 34.84 34.84 1,415,785
Feb 6, 2026 34.38 35.02 34.11 34.91 34.91 1,938,870
Feb 5, 2026 34.10 34.73 33.35 33.55 33.55 1,572,384
Feb 4, 2026 34.56 34.93 34.03 34.13 34.13 1,467,426
Feb 3, 2026 34.64 35.12 34.26 34.47 34.47 1,492,277
Feb 2, 2026 33.54 35.30 33.43 34.96 34.96 1,826,158
Jan 30, 2026 34.58 34.96 33.75 33.89 33.89 2,388,385
Jan 29, 2026 34.12 35.29 34.00 34.88 34.88 2,817,294
Jan 28, 2026 33.92 34.40 33.55 33.90 33.90 1,727,891
Jan 27, 2026 33.11 33.58 32.49 33.52 33.52 1,557,693
Jan 26, 2026 33.38 33.99 32.78 33.11 33.11 2,462,347
Jan 23, 2026 33.95 34.27 33.16 33.61 33.61 3,010,172
Jan 22, 2026 33.85 34.67 33.51 33.95 33.95 2,755,687
Jan 21, 2026 31.79 33.95 31.78 33.85 33.85 3,269,244
Jan 20, 2026 31.42 32.10 31.09 31.75 31.75 2,167,332
Jan 16, 2026 31.38 31.87 31.15 31.63 31.63 2,418,663
Jan 15, 2026 30.51 31.96 30.46 31.22 31.22 2,897,250
Jan 14, 2026 29.26 30.77 29.16 30.62 30.62 1,860,765
Jan 13, 2026 29.53 29.75 28.93 29.15 29.15 2,082,291
Jan 12, 2026 29.58 29.92 29.00 29.62 29.62 1,675,542
Jan 9, 2026 29.73 30.47 29.58 29.66 29.66 2,820,810
Jan 8, 2026 29.06 30.08 29.06 29.60 29.60 2,311,441
Jan 7, 2026 29.00 29.78 28.95 29.36 29.36 2,299,594
Jan 6, 2026 28.01 28.92 27.50 28.78 28.78 2,032,978
Jan 5, 2026 28.09 28.32 27.70 28.00 28.00 1,626,979
Jan 2, 2026 28.01 28.63 27.56 28.26 28.26 1,323,286
Dec 31, 2025 27.95 28.17 27.68 27.98 27.98 1,206,634
Dec 30, 2025 27.86 28.14 27.66 27.81 27.81 1,230,944
Dec 29, 2025 28.61 28.61 27.85 28.01 28.01 923,263
Dec 26, 2025 28.41 28.53 28.32 28.49 28.49 760,113
Dec 24, 2025 28.46 28.75 28.39 28.52 28.52 962,363
Dec 23, 2025 28.67 28.87 28.43 28.49 28.49 957,622
Dec 22, 2025 28.38 28.98 28.02 28.63 28.63 1,366,013
Dec 19, 2025 27.91 28.65 27.82 28.45 28.45 4,281,490
Dec 18, 2025 28.23 28.50 27.69 27.81 27.81 1,502,249
Dec 17, 2025 28.22 28.52 27.85 28.04 28.04 1,929,936
Dec 16, 2025 28.10 28.27 27.53 28.06 28.06 1,696,533
Dec 15, 2025 28.72 28.79 28.00 28.17 28.17 1,991,993
Dec 12, 2025 29.26 29.35 28.42 28.50 28.50 1,620,234
Dec 11, 2025 28.73 29.34 28.55 29.17 29.17 1,567,370
Dec 10, 2025 28.52 28.77 27.80 28.62 28.62 2,209,134
Dec 9, 2025 29.41 29.68 28.42 28.44 28.44 2,089,000
Dec 8, 2025 29.55 29.80 29.12 29.41 29.41 1,709,029
Dec 5, 2025 29.16 29.59 28.97 29.52 29.52 1,810,097
Dec 4, 2025 29.53 29.66 28.96 29.30 29.30 1,376,057
Dec 3, 2025 29.21 30.10 28.97 29.53 29.53 1,454,539
Dec 2, 2025 29.27 29.48 28.52 28.97 28.97 1,837,786
Dec 1, 2025 29.30 29.47 28.85 28.90 28.90 1,539,844
Nov 28, 2025 29.85 30.23 29.24 29.58 29.58 1,120,425
Nov 26, 2025 28.93 30.05 28.67 29.72 29.72 2,530,324
Nov 25, 2025 28.38 29.06 28.19 28.99 28.99 1,601,940
Nov 24, 2025 28.55 28.63 27.89 28.20 28.20 2,490,246
Nov 21, 2025 28.10 28.87 28.06 28.61 28.61 2,039,006
Nov 20, 2025 28.86 29.24 28.12 28.19 28.19 1,433,066
Nov 19, 2025 29.02 29.27 28.50 28.69 28.69 1,725,566
Nov 18, 2025 29.57 29.86 28.84 29.26 29.26 3,103,489
Nov 17, 2025 29.36 30.27 29.12 29.33 29.33 2,869,203
Nov 14, 2025 30.22 30.36 28.67 29.04 29.04 5,749,552
Nov 13, 2025 30.60 31.73 30.60 31.01 31.01 3,354,295
Nov 12, 2025 27.97 31.62 27.49 31.41 31.41 8,561,636
Nov 11, 2025 33.08 34.45 32.51 33.81 33.81 1,888,217
Nov 10, 2025 32.89 33.47 32.23 32.65 32.65 1,748,670
Nov 7, 2025 31.89 32.95 31.41 32.89 32.89 1,990,394
Nov 6, 2025 31.03 32.49 30.66 31.68 31.68 2,124,294
Nov 5, 2025 32.01 36.32 31.00 31.07 31.07 6,993,235
Nov 4, 2025 30.00 30.63 29.77 30.39 30.39 2,317,234
Nov 3, 2025 30.34 30.69 29.70 30.17 30.17 2,452,737
Oct 31, 2025 30.70 31.00 30.35 30.70 30.70 2,020,726
Oct 30, 2025 31.29 32.13 30.73 30.82 30.82 2,269,251
Oct 29, 2025 31.00 31.90 30.66 31.45 31.45 2,348,215
Oct 28, 2025 30.25 31.48 28.41 31.00 31.00 4,965,715
Oct 27, 2025 30.05 30.39 29.45 29.72 29.72 2,928,248
Oct 24, 2025 30.30 30.51 29.53 29.80 29.80 2,079,672
Oct 23, 2025 31.22 31.22 29.93 30.04 30.04 4,317,116
Oct 22, 2025 30.00 32.02 29.93 31.09 31.09 4,325,789
Oct 21, 2025 30.98 31.91 30.78 31.45 31.45 1,633,444
Oct 20, 2025 30.52 31.27 30.07 30.98 30.98 1,649,025
Oct 17, 2025 30.68 31.18 30.00 30.26 30.26 2,042,357
Oct 16, 2025 32.11 32.29 30.40 30.80 30.80 2,284,570
Oct 15, 2025 31.51 32.40 31.42 32.23 32.23 1,315,923
Oct 14, 2025 32.00 32.20 31.59 31.94 31.94 2,977,554
Oct 13, 2025 31.39 32.31 31.25 32.17 32.17 1,691,680
Oct 10, 2025 31.38 31.52 30.77 31.21 31.21 2,759,247
Oct 9, 2025 31.63 32.02 31.29 31.38 31.38 1,562,728
Oct 8, 2025 31.15 31.82 30.81 31.51 31.51 1,084,383
Oct 7, 2025 31.09 31.10 30.70 30.95 30.95 1,054,709
Oct 6, 2025 30.87 31.30 30.74 30.99 30.99 1,619,244
Oct 3, 2025 31.17 31.68 30.98 31.06 31.06 1,687,516
Oct 2, 2025 30.53 31.32 30.50 31.26 31.26 1,593,926
Oct 1, 2025 30.07 30.74 29.85 30.65 30.65 1,592,481
Sep 30, 2025 28.95 30.17 28.95 30.00 30.00 2,299,113
Sep 29, 2025 27.74 29.14 27.60 29.04 29.04 2,745,786
Sep 26, 2025 28.20 28.55 27.57 27.89 27.89 2,340,103
Sep 25, 2025 27.79 27.79 26.99 27.13 27.13 1,086,540
Sep 24, 2025 27.74 28.25 27.56 27.81 27.81 1,120,346
Sep 23, 2025 27.49 28.03 27.46 27.75 27.75 1,740,349
Sep 22, 2025 27.87 28.16 27.52 27.63 27.63 2,002,584

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Alkermes Inc. plc Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at ALKS, per a recent SEC DEF 14A filing. We estimate that the median employee at Alkermes plc. is paid $225,915.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation